Advertisement
Original article| Volume 108, ISSUE 1, P23-29, July 1986

Effect of allopurinol on the renovascular responses to adenosine

  • Juan F. Macias-Nunez
    Footnotes
    Affiliations
    From the Department of Physiology and Biophysics and Divisions of Nephrology and Hypertension, Mayo Clinic and Mayo Foundation Rochester, Minnesota, U.S.A.
    Search for articles by this author
  • Marisa Revert
    Footnotes
    Affiliations
    From the Department of Physiology and Biophysics and Divisions of Nephrology and Hypertension, Mayo Clinic and Mayo Foundation Rochester, Minnesota, U.S.A.
    Search for articles by this author
  • Mary Fiksen-Olsen
    Affiliations
    From the Department of Physiology and Biophysics and Divisions of Nephrology and Hypertension, Mayo Clinic and Mayo Foundation Rochester, Minnesota, U.S.A.
    Search for articles by this author
  • Franklyn G. Knox
    Affiliations
    From the Department of Physiology and Biophysics and Divisions of Nephrology and Hypertension, Mayo Clinic and Mayo Foundation Rochester, Minnesota, U.S.A.
    Search for articles by this author
  • J.Carlos Romero
    Correspondence
    Reprint requests: J. C. Romero, Mayo Clinic, 200 First St. S.W., Rochester, MN 55905.
    Affiliations
    From the Department of Physiology and Biophysics and Divisions of Nephrology and Hypertension, Mayo Clinic and Mayo Foundation Rochester, Minnesota, U.S.A.
    Search for articles by this author
  • Author Footnotes
    ∗ Visiting Scientist; present address: Department of Nephrology, University of Salamanca, Salamanca, Spain.
    1 M. R. was an Interchange Program student from the Autonomous University of Barcelona, Barcelona, Spain.
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      It is known that renal ischemia enhances the production of adenosine, which is further metabolized by xanthine oxidase, and that the inhibition of this metabolizing enzyme by allopurinol ameliorates the consequences of renal ischemia. This study was undertaken to define the effect of allopurinol on the renal responses to adenosine. It was found that 5 minutes of intrarenal infusion of adenosine in control dogs produced a typical biphasic response characterized by an initial vasoconstriction, decreasing renal blood flow by 46.3% ± 6.0%, followed by vasodilatation, increasing renal blood flow by 8.5% ± 3.6% above the control levels. Adenosine infusion was also accompanied by a significant reduction of plasma renin activity, from 8.4 ± 0.6 ng/ml/hour to 3.8 ± 0.4 ng/ml/hour. The administration of an intravenous infusion of 50 mg allopurinol did not alter the vasoconstrictor phase of adenosine—the average decrease was 41.1% ± 3.3%; however, it prevented much of the vasodilatation because renal blood flow over the 5 minutes remained 17.9% ± 5.0% less than the levels recorded before adenosine infusion. Allopurinol also prevented the decrease of plasma renin activity, for which the average values recorded before and after adenosine were 9.6 ± 0.6 ng/ml/hour and 8.2 ± 0.6 ng/ml/hour, respectively. The results of this study indicate that allopurinol exerts specific effects on the vasodilatory component of adenosine and prevents the adenosine-suppressive effect on the renin-angiotensin system.

      Abbreviations:

      ADP (adenosine diphosphate), AMP (adenosine monophosphate), ATP (adenosine triphosphate)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Translational Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Haddy FJ
        • Scott JB
        Metabolically linked vasoactive chemicals in local regulation of blood flow.
        Physiol Rev. 1968; 48: 688-707
        • Hashimoto K
        • Kumakura S
        The pharmacological features of the coronary, renal, mesenteric and femoral arteries.
        Jpn J Physiol. 1965; 15: 540-551
        • Thurau K
        Renal hemodynamics.
        Am J Med. 1964; 36: 689-719
        • Ellis CH
        • Touw KB
        • Dickerson SW
        Some acute hemodynamic effects of large doses of sodium allopurinol in open-chested dogs.
        Arch Int Pharmacodyn Ther. 1973; 205: 355-367
        • Stanley EL
        • Kezdi P
        • Smith T
        Allopurinol, a generalized coronary vasodilator (Abstr).
        Circulation. 1971; 43: 229
        • Osswald H
        • Spielman WS
        • Knox FG
        Mechanism of adenosinemediated decreases in glomerular filtration rate in dogs.
        Circ Res. 1978; 43: 465-469
        • Tagawa H
        • Vander AJ
        Effects of adenosine compounds on renal function and renin secretion in dogs.
        Circ Res. 1970; 26: 327-338
        • Osswald H
        • Schmitz H-J
        • Heidenreich O
        Adenosine response of the rat kidney after saline loading, sodium restriction and hemorrhagia.
        Pflugers Arch. 1975; 357: 323-333
        • Spielman WS
        • Osswald H
        Blockade of postocclusive renal vasoconstriction by an angiotensin II antagonist: evidence for an angiotensin-adenosine interaction.
        Am J Physiol. 1979; 237: F463-F467
        • Thomas RA
        • Rubio R
        • Berne RM
        Adenosine metabolism in the kidney: its possible role in the control of renal blood flow (Abstr).
        in: Fed Proc. 34. 1975: 363
        • Garvin PJ
        • Dowden D
        • Carney K
        • et al.
        Nucleotide enhancement techniques in renal preservation (Abstr).
        Clin Res. 1981; 29: 848
        • Gibson T
        • Simmonds HA
        • Potter C
        • Rogers V
        A controlled study of the effect of long term allopurinol treatment on renal function in gout.
        Adv Exp Med Biol. 1980; 122A: 257-262
        • Elion GB
        • Kovensky A
        • Hitchings HG
        • Metz E
        • Rundles RW
        Metabolic studies of allopurinol, an inhibitor of xanthine oxidase.
        Biochem Pharmacol. 1966; 15: 863-880
        • Vasko KA
        • DeWall RA
        • Riley AM
        Effect of allopurinol in renal ischemia.
        Surgery. 1972; 71: 787-790
        • Toledo-Pereyra LH
        • Najarian JS
        Allopurinol on renal preservation.
        Transplantation. 1975; 20: 256
        • Owens ML
        • Lazarus HM
        • Wolcott MW
        • Maxwell JG
        • Taylor JB
        Allopurinol and hypoxanthine pretreatment of canine kidney donors.
        Transplantation. 1974; 17: 424-427
        • Toledo-Pereyra LH
        • Simmons RL
        • Olson LC
        • Najarian JS
        Clinical effect of allopurinol on preserved kidneys: a randomized double-blind study.
        Ann Surg. 1977; 185: 128-131
        • Murdock MI
        • Cho SI
        The lack of beneficial effect of allopurinol on renal preservation.
        Transplantation. 1975; 19: 353-354
        • Crowell JW
        • Jones CE
        • Smith EE
        Effect of allopurinol on hemorrhagic shock.
        Am J Physiol. 1969; 216: 744-748
        • Dietrich LS
        Factors affecting the induction of xanthine oxidase of mouse liver.
        J Biol Chem. 1954; 211: 79-85
        • Kozhemiakin LA
        • Koreleva TR
        • Korostovtsev DS
        Xanthine-oxidase-xanthine as a system of endogenous regulation of phosphodiesterase activity.
        Bull Exp Biol Med. 1980; 90: 673-675
        • Fridovich SE
        • Porter NA
        Oxidation of arachidonic acid in micelles by superoxide and hydrogen peroxide.
        J Biol Chem. 1981; 256: 260-265
        • Kleinman LI
        • Radford Jr, EP
        Ventilation standards for small mammals.
        J Appl Physiol. 1964; 19: 360-362
        • Britton SL
        • Sexton JM
        • Fiksen-Olsen MJ
        • Werness PG
        • Romero JC
        A comparison of angiotensin II and angiotensin III as vasoconstrictors in the mesenteric circulation of dogs.
        Circ Res. 1980; 46: 146-151
        • Mancia G
        • Romero JC
        • Shepherd JT
        Continuous inhibition of renin release in dogs by vagally innervated receptors in the cardiopulmonary region.
        Circ Res. 1975; 36: 529-535
        • Ohtaki Y
        • Nakanishi H
        • Ueda J
        Effects of adenosine compounds of the vascular bed and effects of dilazep, theophylline, and indomethacin on blood flow changes of the postocclusive renal vessels (Engl. Abstr.).
        Folia Pharmacol Jpn. 1977; 73: 93-102
        • Spielman WS
        • Britton SL
        • Fiksen-Olsen MJ
        Effect of adenosine on the distribution of renal blood flow in dogs.
        Circ Res. 1980; 46: 449-456
        • Borgeat P
        • Samuelsson B
        Metabolism of arachidonic acid in polymorphonuclear leukocytes: structural analysis of novel hydroxylated compounds.
        J Biol Chem. 1979; 254: 7865-7869
        • Rosenthal A
        • Pace-Asciak CR
        Potent vasoconstriction of the isolated perfused rat kidney by leukotrienes C4 and D4.
        Can J Physiol Pharmacol. 1983; 61: 325-328
        • Badr KF
        • Baylis C
        • Pfeffer JM
        • et al.
        Renal and systemic hemodynamic responses to intravenous infusion of leukotriene C4 in the rat.
        Circ Res. 1984; 54: 492-499
        • Feigen LP
        Differential effects of leukotrienes C4, D4, and E4 in the canine renal and mesenteric vascular beds.
        J Pharmacol Exp Ther. 1983; 225: 682-687
        • Chapnick BM
        Divergent influences of leukotrienes C4, D4, and E4 on mesenteric and renal blood flow.
        Am J Physiol. 1984; 246: H518-H524
        • Cunningham SK
        • Keaveny TV
        • Fitzgerald P
        Effect of allopurinol on tissue ATP, ADP and AMP concentrations in renal ischaemia.
        Br J Surg. 1974; 61: 562-565
        • Scott JB
        • Daugherty Jr, RM
        • Dabney JM
        • Haddy FJ
        Role of chemical factors in regulation of flow through kidney, hindlimb and heart.
        Am J Physiol. 1965; 208: 813-824
        • Hansson LO
        The influence of thrombocyte aggregation on renal circulation. An experimental study in the cat.
        Acta Chir Scand. 1965; 345 ([Suppl]): 5-66
        • Ono H
        • Inagaki K
        • Hashimoto K
        A pharmacological approach to the nature of the autoregulation of the renal blood flow.
        Jpn J Physiol. 1966; 16: 625-634
        • Allison DS
        • Tanigawa H
        • Assaykeen TA
        The effects of cyclic nucleotides on plasma renin activity and renal function in dogs.
        in: Assaykeen TA Control of renin secretion. Plenum Press, New York1972: 33-47
        • Okahara T
        • Abe Y
        • Yamamoto K
        Effects of dibutyrl cyclic AMP and propranolol on renin secretion in dogs (39909).
        in: Proc Soc Exp Biol Med. 156. 1977: 213-218
        • Winer N
        • Chokshi DS
        • Walkenhorst WG
        Effects of cyclic AMP, sympathomimetic amines, and adrenergic receptor antagonists on renin secretion.
        Circ Res. 1971; 29: 239-248
        • Abe Y
        • Morimoto S
        • Yamamoto K
        • Ueda J
        Effects of dibutyryl cyclic 3′,5′-adenosine monophosphate on the renal function.
        Jpn J Pharmacol. 1968; 18: 271-272
        • Saito H
        • Nishida H
        • Shudo I
        • Tawara K
        • Monma Y
        • Tanabe T
        On the diuretic action produced by dibutyryl cyclic AMP in dogs.
        Res Commun Chem Pathol Pharmacol. 1975; 10: 391-394